Howard Irwin Schenker, MD

College
Cornell University – Ithaca, NY
BA, 1971

Medical School
Cornell University – Ithaca, NY
MD, 1975

Fellowship
Department of Ophthalmology, Mt. Sinai Medical Center,
New York, NY 1979 –1980: Glaucoma

Research Awards
Grass Foundation, Cornell University Medical College – Ithaca, NY, 1972
Beth Israel Medical Center, New York, 1979 - 1980

Professional Activity
Park Ridge Hospital: Attending physician, 1980
University of Rochester School of Medicine & Dentistry Associate Clinical Professor, 1980
Westfall Surgery Center: Attending physician, 1986
Highland Hospital: Attending physician, 1992

Professional Affiliations
Monroe County Medical Society
American Medical Association
Academy of Ophthalmology
New York State Medical Society
Rochester Academy of Medicine
Rochester Ophthalmological Society

Publications

Exercise- Induced Increase of Intraocular Pressure in the Pigmentary Dispersion Syndrome, Schenker HI, Luntz MH, Kels B, Podos SM, American Journal of Ophthalmology, 89(4):598600, 1980 Apr.

Fluorophotometric Study of Epinephrine and Timolol in Human Subjects, Schenker HI, Yablonski ME, Podos SM, Linder L, Archives of Ophthalmology, 99(7):1212-6, 1981 Jul.

Long-Term IOP Lowering Efficacy and Safety of Timolol Maleate Gel Forming Solution 0.5% Compared to Timoptic XE 0.5% in a 12 Month Study, Howard 1. Schenker, MD, Lewis H. Silver, MD, and the Timoloi Gel Forming Solution Study Group, American Journal of Ophthalmology

Patient Preference, Efficacy, and Compliance with Timolol Maleate Ophthalmic Gel-Forming Solution Versus Timolol Maleate Ophthalmic Solution in Patients with Ocular Hypertension or Open-Angle Glaucoma, H. Schenker, et al., Clinical Therapeutics, Vol. 21, No. 1, p. 138, Jan. 1999.

Retinal Vascular Accidents in Glaucoma and Ocular Hypertension, Luntz MH, Schenker HI, Survey of Ophthalmology, 25(3):163-7,1980 Nov.-Dec.